Crinetics Starts Pediatric Phase 2/3 Trial For Atumelnant In CAH
22 Jan 2026 //
GLOBENEWSWIRE
Crinetics Unveils New Data, Funding as Neurocrine Rival
07 Jan 2026 //
BIOSPACE
Crinetics Reports Strong PALSONIFY Launch, Positive CAH Data
05 Jan 2026 //
GLOBENEWSWIRE
Crinetics Pharma Announces PALSONIFY & Atumelnant Update
04 Jan 2026 //
GLOBENEWSWIRE
Crinetics Announces First Patient Dosed in Adrenal Hyperplasia
11 Dec 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support